Stocks TelegraphStocks Telegraph
Screener NEW

MNKD Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:MNKD

MannKind Corporation

$7.22
0.1258+1.77%
Open: 12:23 PM
57.88
BESG ScoreESG Rating
Loading...

Stock Price Today

MannKind Corporation (MNKD) stock surged +1.77%, trading at $7.22 on NASDAQ, up from the previous close of $7.09. The stock opened at $7.02, fluctuating between $7.01 and $7.23 in the recent session.

Stock Snapshot

7.09
Prev. Close
7.02
Open
1.98B
Market Cap
275M
Number of Shares
7.01
Day Low
7.23
Day High
144.32
P/E Ratio
96.88%
Free Float in %
0.05
EPS (TTM)
-0.91
Book Value
-0.03
Cash Flow per Share
522.37K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Nov 04, 20247.187.337.067.092.28M
Nov 01, 20247.167.307.107.172.47M
Oct 31, 20247.057.156.777.073.62M
Oct 30, 20246.917.146.837.023.16M
Oct 29, 20246.827.096.806.873.83M
Oct 28, 20246.586.906.576.832.42M
Oct 25, 20246.506.646.416.541.32M
Oct 24, 20246.476.516.316.431.56M
Oct 23, 20246.636.676.496.49985.37K
Oct 22, 20246.566.726.566.64935.23K
Oct 21, 20246.576.676.556.631.64M
Oct 18, 20246.636.676.576.60910.69K
Oct 17, 20246.776.806.546.601.33M
Oct 16, 20246.626.806.626.731.75M
Oct 15, 20246.546.686.506.611.49M
Oct 14, 20246.486.616.406.551.59M
Oct 11, 20246.356.496.326.481.28M
Oct 10, 20246.366.406.256.321.32M
Oct 09, 20246.466.496.366.431.03M
Oct 08, 20246.346.566.316.461.41M

Contact Details

Westlake Village, CA 91362

United States

Website: https://www.mannkindcorp.comContact: 818 661 5000

About Company

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

Company Information

Employees411
Beta1.313
Sales or Revenue$198.96M
5Y Sales Change%2.855%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current MannKind Corporation (MNKD) stock price?

MannKind Corporation (NASDAQ: MNKD) stock price is $7.22 in the last trading session. During the trading session, MNKD stock reached the peak price of $7.23 while $7.01 was the lowest point it dropped to. The percentage change in MNKD stock occurred in the recent session was 1.77% while the dollar amount for the price change in MNKD stock was $0.13.

MNKD's industry and sector of operation?

The NASDAQ listed MNKD is part of Biotechnology industry that operates in the broader Healthcare sector. MannKind Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNKD?

Ms. Rosabel Realica Alinaya
Vice President of Investor Relations & Treasury
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
Dr. Stuart A. Tross Ph.D.
Executive Vice President and Chief People & Workplace Officer
Mr. Joseph Kocinsky M.B.A., M.S.
Chief Technology Officer
Dr. Michael E. Castagna Pharm.D.
Chief Executive Officer & Director
Mr. Steven B. Binder
Chief Financial Officer
Dr. David B. Thomson
Executive Vice President, Gen. Counsel & Sec.
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Lauren M. Sabella
Executive Vice President & Chief Operating Officer
Mr. Thomas Hofmann M.D., Ph.D.
Senior Vice President & Chief Scientific Officer

How MNKD did perform over past 52-week?

MNKD's closing price is 123.66% higher than its 52-week low of $3.17 where as its distance from 52-week high of $7.33 is -3.21%.

How many employees does MNKD have?

Number of MNKD employees currently stands at 411.

Link for MNKD official website?

Official Website of MNKD is: https://www.mannkindcorp.com

How do I contact MNKD?

MNKD could be contacted at phone 818 661 5000 and can also be accessed through its website. MNKD operates from 30930 Russell Ranch Road, Westlake Village, CA 91362, United States.

How many shares of MNKD are traded daily?

MNKD stock volume for the day was 522.37K shares. The average number of MNKD shares traded daily for last 3 months was 2.32M.

What is the market cap of MNKD currently?

The market value of MNKD currently stands at $1.98B with its latest stock price at $7.22 and 275M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph